This study established the newly identified HSPA8-GEMIN5 complex as a molecular hub mediating “splicing-translation coupling” in CRC and provided a novel “dual-pathway intervention targeting splicing and translation” strategy inducing proteostasis imbalance for CRC therapy. Here, HSPA8 is linked to colorectal carcinoma.